Growth rate-corrected (GR) dose-response metric signatures across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 3 of 4: Median, upper quartile, and lower quartile GR metrics per perturbagen. - Dataset (ID:20270)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10110-3 | FR180204 | FR 180204; KIN001-230 | LSM-42790 |  | 11493598 |
| 10259-1 | ICRF-193 | LSM-4280 |  | 115150 | |
| 10175-3 | Sunitinib | Sutent; SU11248 | LSM-42800 |  | 3086686 |
| 10262-1 | L-779450 | LSM-4283 |  | 9950176 | |
| 10263-1 | LBH589 | Panobinostat | LSM-4284 |  | 57519507 |
| 10267-1 | NU6102 | LSM-4287 |  | 4566 | |
| 10270-1 | Oxamflatin | LSM-4290 |  | 4611 | |
| 10274-1 | SB-3CT | LSM-4293 |  | 9883002 | |
| 10277-1 | Temsirolimus | LSM-4295 |  | 148191 | |
| 10283-1 | XRP44X | AG-G-87906 | LSM-4298 |  | 10339779 |
| 10279-1 | Trichostatin A | LSM-43005 |  | ||
| 10133-2 | Afatinib | BIBW-2992 | LSM-43226 |  | 57519523 |
| 10236-1 | 17-AAG | Tanespimycin | LSM-43239 |  | 151069 |
| 10261-1 | Ixabepilone | Azaepothilone B; Ixempra | LSM-43293 |  | 216344 |
| 10275-1 | (Z)-4-Hydroxytamoxifen | LSM-43294 |  | 53770298 | |
| 10269-1 | Oxaliplatin | Eloxatin | LSM-44941 |  | 5310940 |
| 10242-1 | Carboplatin | LSM-44959 |  | 5237030 | |
| 10346-1 | Valproic acid | Depakine | LSM-4620 |  | 3549980 |
| 10252-1 | Gemcitabine | Gemzar | LSM-5333 |  | 60750 |
| 10278-1 | Topotecan | Hycamtin | LSM-5662 |  | 60700 |
| 10264-1 | Methotrexate | Rheumatrex; Trexall; Amethopterin; MTX | LSM-5690 |  | 126941 |
| 10260-1 | Ispinesib | SB-715992 | LSM-5732 |  | 6851740 |
| 10265-1 | Pevonedistat | MLN 4924; MLN-4924; MLN4924 | LSM-6263 |  | 16720766 |
| 10241-4 | Bortezomib | Velcade | LSM-6281 |  | 387447 |
| 10241-1 | Bortezomib | Velcade | LSM-6281 | | 387447 |